FR2183041B1 - - Google Patents

Info

Publication number
FR2183041B1
FR2183041B1 FR7315207A FR7315207A FR2183041B1 FR 2183041 B1 FR2183041 B1 FR 2183041B1 FR 7315207 A FR7315207 A FR 7315207A FR 7315207 A FR7315207 A FR 7315207A FR 2183041 B1 FR2183041 B1 FR 2183041B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7315207A
Other languages
French (fr)
Other versions
FR2183041A1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2183041A1 publication Critical patent/FR2183041A1/fr
Application granted granted Critical
Publication of FR2183041B1 publication Critical patent/FR2183041B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7315207A 1972-04-27 1973-04-26 Expired FR2183041B1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24801372A 1972-04-27 1972-04-27

Publications (2)

Publication Number Publication Date
FR2183041A1 FR2183041A1 (xx) 1973-12-14
FR2183041B1 true FR2183041B1 (xx) 1977-11-10

Family

ID=22937288

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7315207A Expired FR2183041B1 (xx) 1972-04-27 1973-04-26

Country Status (8)

Country Link
JP (2) JPS5939426B2 (xx)
BE (1) BE798829A (xx)
CH (1) CH585198A5 (xx)
FR (1) FR2183041B1 (xx)
GB (2) GB1396207A (xx)
HU (1) HU168570B (xx)
NL (1) NL7305817A (xx)
ZA (1) ZA732244B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4052446A (en) * 1973-08-06 1977-10-04 Hoffmann-La Roche Inc. 11,16-substituted prostaglandins
US4017534A (en) * 1974-06-03 1977-04-12 American Cyanamid Company 16-Fluoro-11-deoxy-13-dihydro-prostaglandin
JPS52145350A (en) * 1976-05-31 1977-12-03 Hitachi Ltd Complete fillet welding of tee joint having vvshaped groove
JPS5524138A (en) * 1978-08-11 1980-02-21 Toray Ind Inc Optically active synthetic intermediate and its preparation
DE3469736D1 (de) * 1983-09-07 1988-04-14 Indiana University Foundation 12, 16-difluoroprostaglandin f2 alpha compounds
GB8324004D0 (en) * 1983-09-07 1983-10-12 Erba Farmitalia 16-fluoro-16 17-didehydro prostanoids
AR035242A1 (es) * 2001-05-18 2004-05-05 Sucampo Ag Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado
CN110218776A (zh) * 2019-06-14 2019-09-10 苏州叠代生物科技有限公司 Pcr油相组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL32552A (en) * 1968-07-29 1975-07-28 Upjohn Co Prostaglandin analogs
BR6915068D0 (pt) * 1969-03-14 1973-05-24 Upjohn Co Processo de producao de derivados racemicos de prostaglandina

Also Published As

Publication number Publication date
BE798829A (fr) 1973-10-29
FR2183041A1 (xx) 1973-12-14
NL7305817A (xx) 1973-10-30
GB1396207A (en) 1975-06-04
CH585198A5 (xx) 1977-02-28
JPS5938235B2 (ja) 1984-09-14
ZA732244B (en) 1974-03-27
JPS5993070A (ja) 1984-05-29
JPS4914458A (xx) 1974-02-07
JPS5939426B2 (ja) 1984-09-22
GB1396206A (en) 1975-06-04
HU168570B (xx) 1976-05-28

Similar Documents

Publication Publication Date Title
JPS4948726A (xx)
FR2183041B1 (xx)
FR2178783B1 (xx)
JPS5331592B2 (xx)
FR2173982A1 (xx)
JPS5021703B2 (xx)
JPS5229219Y2 (xx)
JPS5233170B2 (xx)
JPS5242862Y2 (xx)
JPS5224714Y2 (xx)
JPS5148687B2 (xx)
CS159442B1 (xx)
JPS49103029U (xx)
CS165917B1 (xx)
CS163959B1 (xx)
CS163386B1 (xx)
CS156687B1 (xx)
CS156329B1 (xx)
CS157994B1 (xx)
JPS4973846U (xx)
CH566825A (xx)
CH315973A4 (xx)
CH570503A5 (xx)
CH564416A5 (xx)
CH571764A5 (xx)

Legal Events

Date Code Title Description
ST Notification of lapse